Resource Center
FEATURED
- E-Publication
FEATURED
- Blog
FEATURED
- Case Study
Content type
Topic
Sort By:
- Blog
Speed to patient is a primary driver behind the industry’s shift toward modern commissioning and qualification (C&Q) practices, while still ensuring product quality and...
- E-Publication
- Blog
The 2023 revision of EU GMP Annex 1 reset the global standard for sterile manufacturing. It expands the guidance, tightens contamination-control expectations and aligns...
- Blog
The Windsor Framework (WF), which came into effect on January 1, 2025, is a significant agreement between the UK and the EU that replaces...
- Blog
August 11, 2025 – Indianapolis, IN — CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce...
- Case Study
- Blog
In 2008, the FDA issued guidance exempting most Phase 1 investigational drugs from the full scope of Title 21 of the Code of Federal...
- Case Study
- Case Study